T he use of 18 F-fluorodeoxyglucose positron emission tomography ( 18 F-FDG-PET) in various malignancies is rapidly evolving; however, 18 F-FDG uptake is not tumor specific. Aside from physiological uptake in Waldeyer's ring, the gastrointestinal tract, orbital muscles, cerebral cortex, myocardium, renal collecting systems, bladder, gonads, and brown fat, 18 F-FDG also may accumulate in benign processes, the majority of which are inflammatory. 1, 2 Knowledge of these potentially false-positive lesions is essential for accurate PET interpretation in oncologic patients.
Recently, a systematic review of PET/computed tomography (CT) studies was performed in oncologic patients during a 6-month period and has shown that benign, nonphysiological uptake of 18 F-FDG is encountered in more than 25% of studies. In more than half of them, 18 F-FDG uptake may be moderate or marked as compared with background activity. More than 73% of benign lesions were inflammatory in nature, with post-traumatic bone and soft-tissue abnormalities (including iatrogenic injury) in addition to benign tumors accounting for most of the remaining lesions. 3 Differentiating benign from malignant uptake of 18 F-FDG on PET alone may be particularly challenging because of the low anatomical resolution of PET and paucity of anatomical data. Fusion imaging, namely PET/CT, has been shown to improve not only the sensitivity of PET interpretation but also its specificity. 4, 5 Aside from better anatomical localization of lesions on PET/CT, morphological characterization on CT often may improve the diagnostic accuracy of nonspecific 18 F-FDG avid lesions. [5] [6] [7] A confident benign diagnosis can often be made with CT correlation on fused PET/CT, obviating the need for further evaluation or biopsy in over a third of lesions. 3 Data regarding benign lesions showing an abnormal uptake of 18 F -FDG are sporadic in the literature and mainly are found in the form of case reports. We have tabulated our experience with benign entities associated with increased 18 F-FDG uptake on whole-body PET/CT from more than 12,000 whole-body 18 F-FDG-PET/CT scans performed during a 4-year period.
F-FDG Uptake in Inflammation: Pathophysiology
Inflammation is the primary response of the immune system to infection or irritation, as well as to trauma. In response to these stimuli, a cascade of events occurs, including local hyperemia, release of proteins such as fibrin and immunoglobulins, leakage of fluids, and infiltration of inflammatory cells. 8 Increased uptake of 18 F-FDG in inflammation may be explained by the recruitment of activated white blood cells (granulocytes, lymphocytes, and macrophages), which have enhanced levels of glucose transporters, especially GLUT 3 and GLUT 1, 9 as well as increased affinity to 18 F-FDG through various cytokines and growth factors. One such cytokine is tumor necrosis factor-␣, produced primarily by monocytes, which has been shown to activate macrophages in experimental models of inflammation as well as clinically in rheumatoid arthritis or in response to bacterial endotoxins. 10, 11 Activated monocytes directly activate reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, which imposes an acute metabolic demand met by an increased use of both internal energy stores and exogenous metabolites such as glucose. 12, 13 Recently, in vitro studies have shown that the activation of monocytes, without further activation of NADPH oxidase, is sufficient to increase glucose metabolism. 12 These pathophysiologic processes are the basis for increased uptake of 18 F-FDG that is encountered in acute inflammatory processes. Although uptake of 18 F-FDG in inflammation may cause false-positive PET interpretation in oncology patients, it may be exploited to assess inflammation. 18 F-FDG-PET has been used to assess the activity of inflammatory disease and response to therapy in several diseases such as sarcoidosis and vasculitis. 14, 15 In patients with large-vessel vasculitis, 18 F-FDG uptake has been shown to correlate well with the level of acute phase reactant markers and thus with activity of inflammation. 15 Even in the presence of severe immunosuppression, 18 F-FDG-PET can detect the presence and extent of infectious foci not identified with conventional diagnostic methods, even when clinically silent. Therefore, PET may lead to modifications in the therapeutic strategy in this clinical scenario. 16 
Infection and Inflammation

Head and Neck
Infections in the head and neck region are common and may involve the sinonasal cavities, pharynx, tonsils, ears, and mastoids ( Table 1) . As a general rule of thumb, acute inflammatory processes tend to show greater intensity of 18 F-FDG uptake than chronic processes. Occasionally, it may be impossible to differentiate malignancy from inflammation ( Fig. 1) . In these cases, clinical correlation with close imaging follow-up may be useful. In other clinical instances, especially when the patient's primary malignancy is not in the head and neck region, a benign diagnosis can be suggested based on an unusual location for metastatic involvement, or when there is a clear difference in FDG-avidity of the known malignancy and an incidental lesion. Inflammatory disorders of the salivary glands may be infectious (viral or bacterial), granulomatous (typical or atypical mycobacterial infection, sarcoidosis, Wegner's granulomatosis), autoimmune (Sjogren's syndrome), or secondary to obstruction (Fig. 2) . 17 Uptake of 18 F-FDG in salivary glands also may be iatrogenic. Inclusion of the salivary glands in an irradiation field may result in disruption of serous acini, which are extremely radiosensitive, with leakage of enzymes into the surrounding salivary tissues results in an acute inflammatory process. In general, uptake of 18 F-FDG in radiation field may be of high intensity within the first few weeks of radiation therapy as the result of inflammation; therefore, it is recommended to postpone restaging until 4 to 8 weeks from completion of radiation therapy, if clinically possible. 18 
Chest
As previously described in the literature, inflammatory pulmonary lesions may show increased uptake of 18 F-FDG ( Fig.  3 ; Table 2 ). 19 When uptake is focal, it may be indistinguishable on PET from that of a primary or secondary neoplastic lesion (Fig. 3A) . However, some lesions may be characterized as benign based on their appearance on CT. Lipoid pneumonia is a rare type of pneumonia caused by aspiration of mineral, vegetable, or animal oils, usually secondary to neuromuscular disorders associated with dysphagia. The characteristic histological features include lipid-laden macrophages in the alveolar walls and lung interstitium, with associated inflammation and fibrosis. On CT, a low-attenuation nodule, mass, or consolidation with regions of fat-attenuation is suggestive of this entity. 20 Increased uptake of 18 F-FDG has been previously described, likely the result of an abundance of activated macrophages (Fig. 3B) . 21 Similarly, pulmonary Langerhans cell histiocytosis, an isolated form of histiocytosis X, which primarily affects smokers, may be associated with increased uptake of 18 F-FDG. A typical CT appearance is that of pulmonary cysts and nodules predominantly affecting the upper and midlung zones. Early in the course of disease, a predominantly nodular pattern may be encountered, whereas variably shaped cysts are typical of progressive disease. 22 At times, although not pathognomonic, the CT imaging pattern may be suggestive of a specific diagnosis. Lung infarction secondary to pulmonary embolism may be an additional pitfall on 18 F-FDG-PET, especially in patients with malignancy who are at risk for thromboembolism. In our experience, pulmonary infarcts showed only mild uptake of 18 F-FDG, not posing a major diagnostic dilemma. However, uptake may be moderate or marked and may mimic malignancy. 23 In the appropriate clinical setting, a wedge-shaped peripheral region of consolidation on CT should raise the possibility of a pulmonary infarct (Fig. 3C) .
Drug-induced lung toxicity is a relatively frequent complication in oncologic patients, with multiple cytotoxic drugs implicated (Fig. 4A) . The clinical presentation and imaging findings depend on the pathologic processes induced by these drugs, which may include interstitial pneumonitis, diffuse alveolar damage, hemorrhage, edema, and cryptogenic organizing pneumonia (COP; previously known as bronchi- olitis obliterans with organizing pneumonia, or BOOP), among others. 24 Histologically, COP is characterized by the proliferation of immature fibroblastic plugs within respiratory bronchioles, alveolar ducts, and adjacent alveolar spaces. Aside from drug therapy, it may be anteceded by previous lung infection, or may be seen in patients with collagen vascular disease. Case reports have shown that increased 18 F-FDG uptake may be associated with COP, 25 as was also found in our experience (Fig. 4B) . On CT, consolidation involving subpleural and peribronchial areas are the most common finding, followed by ground-glass opacity and nodules. 26 Although none of these features is pathognomonic, in the appropriate clinical setting, when abnormal uptake of FDG is observed in such pulmonary findings on CT, drug toxicity or COP should be considered. Aside from COP, idiopathic interstitial pneumonitides include usual interstitial pneumonitis, nonspecific interstitial pneumonitis, desquamative interstitial pneumonitis, respiratory bronchiolitis-associated interstitial lung disease, acute interstitial pneumonitis, and lymphoid interstitial pneumonitis. Lymphoid interstitial pneumonitis results from progressive alveolocapillary block caused by nodular lymphoid hyperplasia and lymphocytic infiltrate in the interlobular and interalveolar septa and may be secondary to a variety of immunologic and autoimmune diseases (Fig. 4C) .
Imaging findings in these disorders are nonspecific and may be identical to those found in other conditions, including collagen vascular disease or inhalational exposure. 27 Recently, it has been shown that 18 F-FDG-PET may be helpful in the evaluation of idiopathic interstitial pneumonitides. Increased activity on PET may suggest active disease, and a decrease in 18 F-FDG uptake correlates with response to therapy. 28 Radiation pneumonitis may occur 2 to 6 months after completion of radiation therapy in 2 separate phases: acute pneumonitis and chronic lung fibrosis. The acute phase is characterized by loss of type I pneumocytes, increased capillary permeability and edema, and inflammation within alveolar spaces. This phase occurs when radiation therapy exceeds a threshold dose. Usually, radiation pneumonitis is limited to the radiation field. On PET/CT, a sharp linear demarcation is seen separating inflamed and normal lung tissue, suggestive of this entity. Later, pulmonary fibrosis may follow, with concomitant decrease in uptake of 18 F-FDG. Recently, increased metabolic activity on 18 F-FDG-PET has been demonstrated in nonirradiated lung fields as well as along pleural surfaces. 29 The mechanism for this is not well understood, but it has been postulated that radiationinduced damage may begin in the pleura.
Abdomen and Pelvis
Gastrointestinal Tract (Table 3) Physiological uptake of 18 F-FDG along the gastrointestinal tract is variable among patients. Most often it is observed in the gastro-esophageal junction, ileocecal valve region, and right colon, but at times, it may be all along the small and large intestine. The origin of 18 F-FDG uptake in the digestive tract is unknown; however, possible causes that have been suggested are active smooth muscle, metabolically active mucosa, or swallowed secretions. Segmental uptake, especially when associated with bowel wall thickening with or without stranding of adjacent mesenteric fat on CT, may suggest focal inflammation. 30 These findings may be observed anywhere along the gastrointestinal tract. Direct correlation with CT may correctly suggest acute diverticulitis (Fig. 5A ), acute appendicitis, or active inflammatory bowel disease (Fig. 5B) . However, at times, only endoscopy and biopsy may exclude malignancy (Fig. 5C ).
Immunocompromised patients are prone to bowel infections such as typhlitis (neutropenic enterocolitis) after antitumoral therapy. Typhlitis is an uncommon complication of stem cell transplantation involving the distal ileum and right colon, or may occur in other immunosuppressed patients such as those with leukemia (Fig. 6A ). Edema and severe inflammatory changes in bowel wall may result in bowel perforation. At CT, cecal distention and circumferential thickening of the bowel wall are hallmark findings. Bowel wall thickening may have low attenuation secondary to submucosal edema. Inflammatory stranding of the adjacent mesenteric fat is a common accompanying finding. Detection of complications on the CT portion of the PET/CT study such as pneumatosis or pneumoperitoneum is important because it indicates bowel ischemia/infarction and bowel perforation, respectively, and a need for urgent surgical management. 31 These can be visualized.
Allogeneic stem cell transplant recipients are at risk for developing graft versus host disease (GVHD), a morbid clinical condition. Acute GVHD usually develops within the first 3 months after transplantation and is usually preceded by the development of a maculopapular rash. Although any part of the gastrointestinal tract may be involved, the most common segments of bowel to be affected are the small bowel and colon. Denuded gastrointestinal mucosa is replaced by granulation tissue. On CT, the characteristic findings are hyperemic bowel mucosa surrounded by lower-attenuation outer bowel wall layers ("target sign"), bowel loop separation, and mesenteric fat stranding. 32 Imaging findings overlap with those of infectious processes involving the bowel. Because therapy for GVHD includes the use of immunosuppressive drugs, tissue sampling often is necessary to make a definitive diagnosis and exclude infection. The chronic form of GVHD occurs 3 or more months after transplantation, is a major cause of late morbidity and mortality, and is a major risk factor for late infection (Fig. 6B) . In our experience, on 18 F-FDG-PET/CT, low-intensity uptake of 18 F-FDG in thickened loops of bowel may be encountered. These findings, along with an appropriate clinical history, may assist in making an accurate diagnosis.
Liver, Gallbladder, Biliary Tract, Pancreas, Spleen and Peritoneum (Table 4 ) Liver abscesses may be classified as pyogenic, fungal, or parasitic. Liver infection may result from dissemination of organisms from a gastrointestinal infection via the portal vein, as is the case in amebic hepatic abscess, 33 or from sepsis via the hepatic artery, as is the case with most fungal hepatic abscesses. 34 In the modern era, the most common route for pyogenic liver infection is through the biliary tract, ie, ascending cholangitis. Histologically, a liver abscess is composed of a liquefied cavity filled with debris, lined by chronic inflammatory infiltrate consisting of macrophages, lymphocytes, eosinophils, and neutrophils. 33, 35 Therefore, any abscess in the liver, whether pyogenic, fungal, or parasitic, may be associated with increased 18 F-FDG uptake (Fig. 7A) .
Echinococcus of the liver is a parasitic infection, endemic in the Mediterranean basin and other sheep-raising countries. Humans become infected by ingestion of eggs of the tapeworm Echinococcus granulosus, either by eating contaminated food or through contact with dogs. A hydatid cyst of echinococcal infection is composed of 3 layers. The 2 inner layers consist of the endocyst, an inner germinal layer, and the ectocyst, a translucent thin interleaved membrane. The outer pericyst consists of host inflammatory reaction producing a zone of fibroblasts, giant cells, mononuclear cells, and eosinophilic cells. 36 This inflammatory infiltrate may explain the increased uptake of 18 F-FDG, which may be found in the periphery of these cysts on PET (Fig. 7B) . It is yet to be determined whether uptake of 18 F-FDG corresponds to disease activity in echinococcal liver infection.
The most common etiology for acute cholecystitis and ascending cholangitis is cholelithiasis. Ascending cholangitis results from bacterial infection secondary to bile stasis, usually as the result of obstruction. With the appropriate clinical setting, PET/CT images often can make the correct diagnosis of biliary inflammation rather than tumor, especially if a stone is seen on CT (Fig. 8A) . Although acute pancreatitis may have multiple etiologies, the most common are cholelithiasis and alcohol abuse. After a triggering event, pancreatic inflammation occurs at the cellular level and is based on premature activation of pancreatic enzymes leading to autodigestion of the pancreatic parenchyma and peripancreatic tissues. Perilobular or panlobular necrosis affects the acinar cells, islet cells, pancreatic ducts, and interstitial fat. Moreover, extravasation of pancreatic lipase results in the development of peripancreatic fat necrosis. 37 CT findings in pancreatitis may show diffuse or segmental enlargement of the pancreas, with obliteration of peripancreatic fat, necrosis, or pseudocyst formation. On PET/CT, these CT findings are associated with increased 18 F-FDG uptake (Fig. 8B) . Similar to the involvement of the liver, abscess and active granulomatous disease involving the spleen exhibit increased uptake of 18 F-FDG. Granulomatous disease involving the spleen may be infectious, such as by tuberculosis or brucellosis, or inflammatory, such as by sarcoidosis. Occasionally, granulomatous disease may be suggested prospectively on whole-body imaging as the result of multisite involvement and typical imaging patterns. 38 Inflammatory lesions involving the peritoneum and its folds harbor many pitfalls on PET/CT. When PET is performed in the immediate postoperative period, inflammatory postoperative changes may show increased uptake of Crohn's disease. Abnormal uptake of FDG is seen along long segments of small bowel (arrows on middle image). On CT, these loops of small bowel appear concentrically thickened, with mild peri-enteric fat stranding and fibrofatty proliferation, consistent with Crohn's disease (confirmed on endoscopy). (C) Gastritis with gastric ulcer. On PET (middle image), marked focal uptake of FDG in antrum of stomach (arrow). On fused PET/CT (right image), this corresponds to focal thickening of stomach wall (arrow). Endoscopy showed gastritis with benign ulcer in antrum. 18 F-FDG, indistinguishable from uptake in peritoneal malignancy (Fig. 9 ). This can be avoided if PET is performed at least 4 to 6 weeks after surgery. Another potential pitfall on PET is primary epiploic appendagitis (PEA). PEA results from torsion or thrombosis of one of the fatty epiploic appendages projecting from the colonic serosa, which under normal circumstances are indistinguishable from adjacent intra-abdominal fat on CT. However, after infarction, thickening of the visceral peritoneum and hazy infiltration of the fat within the appendage occur, making it visible on CT. The CT findings of PEA are sufficient for a specific diagnosis. 39 PEA may be associated with increased 18 F-FDG uptake and on PET, mimicking malignancy (Fig. 10A) .
Inflammation may involve the mesentery as well. Sclerosing mesenteritis is a benign process of unknown etiology affecting the small bowel mesentery. Most commonly, it is incidentally found on CT, presenting as increased attenuation mesenteric fat containing enlarged mesenteric lymph nodes. Coexisting sclerosing mesenteritis and various neoplastic diseases, most notably lymphoma, gastrointestinal tumors, and urogenital tumors, has been reported. On CT, sclerosing mesenteritis with and without tumoral involvement may appear similar. 40 Although the negative predictive value of 18 F-FDG-PET appears high, false-positive 18 F-FDG-PET with moderate or marked 18 F-FDG uptake may be encountered. 41 The predominant histological changes in PEA and sclerosing mesenteritis are fat necrosis and acute inflammation. Histologically, fat necrosis is characterized by presence of foamy macrophages with a surrounding inflammatory reaction. Monocytes, in general, and macrophages, in particular, are the principal 18 F-FDG-accumulating cells within the inflammation, 42 possibly explaining the significant accumulation of 18 F-FDG in processes resulting in fat necrosis. Other causes for fat necrosis may be due to release of pancreatic enzymes (secondary to pancreatitis or pancreatic surgery), or trauma, including iatrogenic trauma. CT correlation can be used to distinguish fat necrosis from a peritoneal tumor deposit (Fig.  10B) . Radiation therapy is included in the therapeutic regimen of several abdominal and pelvic malignancies. Radiation induces inflammatory changes and increases glucose metabolism; therefore, PET generally is not performed until 2 to 3 months after radiation or chemoradiation. Nonetheless, when performed within a few weeks from completion of radiation therapy, it is often possible to differentiate between radiation-induced inflammation and residual tumor tissue. 43 In our experience, when PET is performed 6 weeks after successful radiation therapy for cervical cancer, only mild uptake of 18 F-FDG is seen, likely indicating resolving radiation-induced inflammatory changes.
Genitourinary Tract (Table 5) Although the kidneys excrete 18 F-FDG, PET may detect focal cortical renal lesions with increased 18 F-FDG uptake. Approximately 60% of renal cell cancers may be 18 F-FDG avid 44 ; however, case reports have shown that focal pyelonephritis and xanthogranulomatous pyelonephritis also may be associated with increased 18 F-FDG uptake. 44, 45 The pathophysiologic basis for imaging findings in acute pyelonephritis is likely multifactorial and has been previously described for CT and magnetic resonance imaging (MRI). Histologically, focal decreased perfusion as the result of edema causes vascular compression and intravascular granulocyte aggregation. In addition, tubular obstruction caused by edema and accumulation of granulocytes result in focal decreased glomerular filtration. 46 These infiltrates of white blood cells may explain the increased 18 F-FDG uptake. As the result of physiological excretion of 18 F-FDG from the kidneys, these focal inflammatory renal masses may be easily overlooked on PET and easier to identify at inspection of maximum intensity projection (MIP) images, as well as fused PET/CT images (Fig. 11) .
Xanthogranulomatous pyelonephritis is an uncommon chronic inflammatory process of the kidney and surrounding tissues, resulting in replacement of renal parenchyma by lipid-laden macrophages. This process is usually diffuse but rarely may be focal. Several predisposing factors have been described, including chronic urinary obstruction and infection and diabetes mellitus. Typical findings on CT include a diffusely enlarged kidney with multiple hypodense masses representing dilated calyces and/or cavities due to parenchymal destruction, with a contracted renal pelvis. Often, an obstructing lesion such as a staghorn calculus may also be identified. CT is particularly useful in determining the extent of the inflammatory process in perirenal tissues including the iliopsoas muscle, abdominal wall, diaphragm, skin, and bowel. 47 An additional potential pitfall with PET imaging may be encountered in adenocarcinomas involving the lower segment of the uterine cavity, or tumors of the cervix. These tumors, when bulky, may result in endocervical stenosis and secondary fluid collections (blood or pus) in the uterine cavity. 48 This may result in increased uptake of 18 F-FDG along the endometrium and should not be confused with tumor extension into the uterus.
Musculoskeletal System 18 F-FDG-PET has been used to localize infectious processes involving the musculoskeletal system (Table 6 ), including chronic infections, which may be clinically challenging to diagnose. 49, 50 It is especially valuable in the evaluation of the axial skeleton, where white blood-cell scans are less useful. 49 In one study of multiple myeloma patients, the use of 18 F-FDG-PET identified infections not detectable by other imaging modalities, even in immunosuppressed patients, accurately determined extent of infection and, on occasion, led to modification of further diagnostic workup and therapy. 50 MRI is considered the modality of choice for early diagnosis of osteomyelitis and for the identification of associated soft-tissue abnormalities such as cellulitis, phlegmon, abscess, sinus tracts, and ulcers. However, MRI findings of acute osteomyelitis may overlap with those of neuropathic osteoarthropathy, biomechanical stress changes related to altered weight bearing, and bone marrow signal changes after orthopedic surgery or trauma. 51 Recently, 18 F-FDG-PET/CT has shown potential as a "single-step" imaging modality for identifying osteomyelitis of the foot in diabetic patients and in differentiating soft-tissue infection from bone involvement. Accurate registration of PET and CT data, as well as evidence of bone destruction or soft-tissue abnormality on CT, was shown to be helpful in making a confident diagnosis in this group of patients. 52 Infection of a joint prosthesis is a serious complication, which may be difficult to differentiate from aseptic loosening. Nonetheless, this distinction is clinically relevant, as patient management of infection requires antimicrobial therapy and likely multiple surgical revisions. 53 Although it has been suggested that 18 F-FDG-PET is less sensitive than conventional radiography for detecting infection and performs similarly to 3-phase bone scintigraphy, 54 it appears that the negative predictive value of PET is high. Therefore, a negative PET result may eliminate the need for revision surgery. 55 Osteoradionecrosis is potentially a significant pitfall in interpretation of 18 F-FDG-PET in oncology patients. The presumed mechanism for 18 F-FDG uptake in osteoradionecrosis is radiation-induced ischemic necrosis along with secondary inflammatory changes. The appearance of radiation necrosis on both PET and conventional imaging often may mimic a metastatic deposit and at times may show very high-level uptake of 18 F-FDG. 56 Correlation with the boundaries of the radiation field and a high index of suspicion are necessary to include osteoradionecrosis in the differential diagnosis in such a clinical scenario. This diagnosis may be particularly relevant when there are no other potential sites of distant metastases and patient management may be dependent on the distinction between tumor and osteoradionecrosis. Arthritis, whether seronegative or seropositive, can be identified on 18 F-FDG-PET. [57] [58] [59] [60] Diffuse uptake of 18 F-FDG in the shoulder girdle is common, with osteoarthritis being the most common etiology. A recent study has shown that 3 PET uptake patterns may apply to 3 different entities: diffuse uptake correlates with osteoarthritis or bursitis; focal uptake at the greater tuberosity correlates with rotator cuff injury; and focal glenoid uptake correlates with frozen shoulder. 57 In rheumatoid arthritis, 18 F-FDG-PET can assess the metabolic activity of synovitis and measure disease activity. Recently, PET findings have been shown to correlate well with MRI and ultrasound assessments of the pannus in rheumatoid arthritis, as well as with serum markers of inflammation, namely, C-reactive protein, and the synovium-derived marker matrix metalloproteinase-3. The pannus is directly responsible for cartilage destruction and bone degradation, and therefore, development of bone erosions and subsequent joint narrowing (Fig. 12) . Uptake of 18 F-FDG is strongly correlated with clinical and laboratory parameters used for assessment of disease activity. 60 Identification of active synovitis in patients with rheumatoid arthritis is thus of utmost importance in determining treatment strategies and assessing response to therapy. In the aforementioned study, changes in SUV after 4 weeks of therapy correlated well with changes in MRI parameters and changes in serum C-reactive protein and matrix metalloproteinase-3 but not with changes in synovial thickness. 59 Although the precise mechanism for 18 F-FDG uptake in rheumatoid arthritis is not completely understood, it is likely related to the presence of activated leukocytes. In addition, tumor necrosis factor-␣, which bears a major role in chronic synovial inflammation, has been shown to enhance glucose entry in macrophages in experimental models of inflammation and regulates glucose transport and metabolism in fibroblasts. [10] [11] [12] Inflammation of supporting structures, such as tendonitis or bursitis, is also commonly identified on routine wholebody 18 F-FDG-PET imaging. Although not always paraneoplastic, dermatomyositis-polymyositis may indicate an increased cancer risk, especially in male patients older than 50 years of age. 61 At times, uptake of 18 F-FDG may be difficult to differentiate from physiological uptake of 18 F-FDG in muscles. 62 Nonetheless, dermatomyositis may show increased uptake of 18 F-FDG in involved muscles. Skin, Lymph Nodes, and Blood Vessels There are a multitude of iatrogenic etiologies for increased uptake of 18 F-FDG in the skin or subcutaneous tissue, including postoperative scar or fluid collections, or postradiation dermatitis (Table 7) . Although subcutaneous injections to the abdominal wall, buttocks or thighs may usually show lowlevel uptake of 18 F-FDG, intradermal injections of bacillus Calmette-Guérin (BCG) may show marked uptake of 18 F-FDG (Fig. 13) . BCG may be used as adjuvant immunotherapy in patients with melanoma and may imitate subcutaneous foci of tumor on both PET and CT. Apart from clinical suspicion and an appropriate history, a clue to the correct diagnosis may be a symmetrical pattern of uptake, which would be unusual for tumor. Increased 18 F-FDG uptake can be observed in the walls of blood vessels involved by large-vessel vasculitis, such as giant cell arteritis and Takayasu's arteritis. 63 PET can aid in accurate localization of involved sites of disease, in selecting a site for biopsy, and in follow-up after therapy. 64 Further work is needed to determine the role of PET in other vasculitides.
Reactive lymph nodes often may be encountered, secondary to localized or generalized inflammatory processes. These nodes are responsible for decreased specificity of 18 F-FDG-PET nodal staging of many malignancies. In our experience, 18 F-FDG may show benign symmetrical perihilar uptake much like that seen on gallium-67 scintigraphy. A recent prospective study on the performance of PET/CT in staging lung cancer has shown that increased uptake of 18 F-FDG may be seen in nodes with calcifications (which have associated higher CT attenuation values than in the surrounding great vessels). On pathology, these nodes contained areas of mild follicular hyperplasia in the cortex and anthracotic change with pigmented macrophages and microscopic fibrotic nod- ule formation in the medulla, consistent with reactive nodes. None of these nodes contained malignant cells. 65 There are systemic lymph node disorders that have been shown to be 18 F-FDG avid. These include Castleman's disease, 66 also known as angiofollicular or giant lymph node hyperplasia, or Rosai-Dorfman disease, a rare condition of unknown etiology. Rosai-Dorfman disease is characterized by massive, painless, lymphadenopathy with or without a low-grade fever. Extranodal involvement is possible. Usually, an indolent chronic clinical course occurs, with occasional exacerbations; however, at times a more aggressive, potentially fatal form is encountered, with destruction of osseous and soft-tissue structures. This too has been shown to be 18 F-FDG avid, 67 as the result of diffuse proliferation of large histiocytic cells.
Benign Tumors and Tumor-Like Conditions
Many benign neoplasms have been shown to be 18 F-FDG avid. These include pituitary adenomas, benign salivary gland tumors, thyroid adenomas, adrenal adenomas and benign pheochromocytomas, and gastrointestinal tract adenomas, among others (Table 8) . [68] [69] [70] There are several benign bone lesions that show significant uptake of 18 F-FDG, most notably fibrous dysplasia, enchondroma, eosinophilic granuloma (Table 9) . 71 Other bone lesions, such as spurs, Schmorl's nodes, bone bridges, and exostoses may show variable uptake of 18 F-FDG. Low-grade uptake of 18 F-FDG may be seen in Paget's disease of the bone and should be included in the differential diagnosis for metastatic disease, 72 especially when the typical CT findings of cortical thickening, trabecular thickening, and bone enlargement are present.
Several benign, tumor-like conditions involving soft tissues may be difficult to differentiate from malignancy on PET ( Tables 8 and 9 ). One such entity is pulmonary amyloidosis. Amyloidosis is a disease caused by extracellular deposition of insoluble proteins. It is usually a systemic disorder and, as such, may affect the lungs in as many as half of cases. Localized forms of pulmonary amyloidosis also have been described. Chest involvement may be tracheobronchial (the most common form), with amyloidomas in the trachea or bronchi, or pulmonary, consisting of multiple or, much less commonly, solitary nodules. 73 Amyloidosis also has been shown to be 18 F-FDG avid and, in our experience, cannot be reliably differentiated from malignancy on PET/CT (Fig. 14) . Lipomatous hypertrophy of the interatrial septum (LHIS) of the heart is a histologically benign process in which increased adipose tissue infiltrates the interatrial septum. Most cases of LHIS have been shown to be 18 F-FDG avid. It has been postulated that variable presence of brown fat in LHIS may be responsible for this uptake. 74 This is also the explanation for marked uptake of 18 F-FDG in hibernomas, which cannot be differentiated from liposarcomas on PET/CT. 75 Diabetic mastopathy of the breast is an uncommon tumorlike fibrous proliferation of the breast. Histologically, it consists of lymphocytic mastitis and stromal fibrosis, mostly in premenopausal women with long-standing type I diabetes mellitus. It is difficult to differentiate on imaging from malignancy. We have encountered one case of diabetic mastopathy that was 18 F-FDG avid. A more comprehensive analysis of this entity is needed to determine the actual avidity of this condition to 18 F-FDG.
Conclusion
In summary, 18 F-FDG is not a tumor specific agent. As such, there are many pitfalls in the reporting of oncology 18 F-FDG-PET studies. Although the majority of these lesions are inflammatory, some are due to benign tumors and tumor-like conditions. A thorough knowledge of these potential pitfalls is necessary to minimize false-positive 18 F-FDG-PET results.
